Tristel plc (AIM:TSTL)
London
· Delayed Price · Currency is GBP · Price in GBX 310.00
-0.02 (-0.01%)
Mar 26, 2025, 10:38 AM GMT+1
Tristel Revenue
Tristel had revenue of 22.57M GBP in the half year ending December 31, 2024, with 29.26% growth. This brings the company's revenue in the last twelve months to 43.56M, up 10.32% year-over-year. In the fiscal year ending June 30, 2024, Tristel had annual revenue of 41.93M with 16.45% growth.
Revenue (ttm)
43.56M
Revenue Growth
+10.32%
P/S Ratio
3.38
Revenue / Employee
186.97K
Employees
233
Market Cap
147.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 41.93M | 5.92M | 16.45% |
| Jun 30, 2023 | 36.01M | 4.89M | 15.70% |
| Jun 30, 2022 | 31.12M | 125.00K | 0.40% |
| Jun 30, 2021 | 31.00M | -680.00K | -2.15% |
| Jun 30, 2020 | 31.68M | 5.51M | 21.05% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Genus | 671.60M |
Tristel News
- 27 days ago - Half Year 2025 Tristel PLC In-person Presentation Transcript - GuruFocus
- 4 weeks ago - Tristel revenue up as it targets opportunities in high-growth markets - The Armchair Trader
- 5 months ago - Full Year 2024 Tristel PLC Analyst briefing Transcript - GuruFocus